Bayer wins latest Roundup cancer trial, ending losing streak

Bayer has gained a trial in a lawsuit introduced by a California man who mentioned he developed most cancers from publicity to its Roundup weedkiller, ending what had been a five-trial shedding streak for the corporate in trials over comparable claims.

The decision was handed down on Friday by a jury in San Benito County, California Superior Courtroom, Bayer introduced. The corporate mentioned in a press release that the decision was “in step with the proof on this case that Roundup doesn’t trigger most cancers and isn’t chargeable for the plaintiff’s sickness.”

Attorneys for plaintiff Bruce Jones didn’t instantly reply to requests for remark. Like most plaintiffs in Roundup lawsuits, Jones alleged that the product precipitated him to develop a type of most cancers referred to as non-Hodgkin lymphoma.

Round 165,000 claims have been made towards the corporate for private accidents allegedly brought on by Roundup, which Bayer acquired as a part of its $63 billion buy of U.S. agrochemical firm Monsanto in 2018.

Earlier than its current string of losses, which produced verdicts towards the corporate totaling greater than $2 billion, Bayer had gained 9 consecutive trials, which means it has now gained 10 of the final 15 trials. Additional instances are anticipated to be tried within the coming yr.

Bayer is interesting the verdicts towards it, which embody massive punitive damages awards which can be prone to be decreased as a result of they exceed U.S. Supreme Courtroom steerage.

The losses had led some traders to query Bayer’s authorized technique in defending the Roundup instances. The corporate mentioned final month that it could proceed preventing the instances in courtroom and had “no urge for food to write down humongous checks” to settle them.

In 2020, Bayer settled many of the then-pending Roundup instances for as much as $9.6 billion however didn’t get a settlement masking future instances. Greater than 50,000 claims stay pending.